We are live on ! Find out more
DADC

D.A. Davidson & Co Portfolio holdings

AUM $18.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+24.63%
3 Year Est. Return
+70.71%
5 Year Est. Return
+77.77%
10 Year Est. Return
+255.18%
AUM
$5.82B
AUM Growth
+$689M
Cap. Flow
+$144M
Cap. Flow %
2.48%
Top 10 Hldgs %
29.76%
Holding
1,206
New
115
Increased
561
Reduced
374
Closed
73

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Industrials 7.64%
3 Financials 7.56%
4 Healthcare 7.3%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIK
1051
DELISTED
Michaels Stores, Inc
MIK
$186K ﹤0.01%
+16,286
New +$223K
DINT icon
1052
Davis Select International ETF
DINT
$279M
$179K ﹤0.01%
10,000
CSQ icon
1053
Calamos Strategic Total Return Fund
CSQ
$3.21B
$175K ﹤0.01%
14,370
+3,680
+34% +$43.9K
CNH
1054
CNH Industrial
CNH
$13.8B
$175K ﹤0.01%
19,710
+334
+2% +$2.99K
NUV icon
1055
Nuveen Municipal Value Fund
NUV
$1.91B
$169K ﹤0.01%
16,923
+8
+0% +$77
PDT
1056
John Hancock Premium Dividend Fund
PDT
$634M
$167K ﹤0.01%
12,069
+216
+2% +$3.41K
TLPH icon
1057
Talphera
TLPH
$70.1M
$164K ﹤0.01%
2,350
PHYS icon
1058
Sprott Physical Gold
PHYS
$14.6B
$159K ﹤0.01%
15,215
-5,571
-27% -$58.7K
CEF icon
1059
Sprott Physical Gold and Silver Trust
CEF
$7.43B
$158K ﹤0.01%
12,725
+2,334
+22% +$29.8K
TEI
1060
Templeton Emerging Markets Income Fund
TEI
$310M
$157K ﹤0.01%
15,359
-200
-1% -$2.05K
SNAP icon
1061
Snap
SNAP
$7.32B
$156K ﹤0.01%
14,170
+200
+1% +$1.7K
VKTX icon
1062
Viking Therapeutics
VKTX
$4.04B
$156K ﹤0.01%
15,720
+2,065
+15% +$17.3K
ATAXZ
1063
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$156K ﹤0.01%
+22,735
New +$156K
ADNT icon
1064
Adient
ADNT
$1.6B
$151K ﹤0.01%
11,558
+1,252
+12% +$21.9K
VTGN icon
1065
VistaGen Therapeutics
VTGN
$9.29M
$147K ﹤0.01%
3,817
+684
+22% +$29.8K
NAD icon
1066
Nuveen Quality Municipal Income Fund
NAD
$2.71B
$144K ﹤0.01%
10,868
-800
-7% -$10.6K
PFL
1067
PIMCO Income Strategy Fund
PFL
$381M
$134K ﹤0.01%
+11,715
New +$133K
EVH icon
1068
Evolent Health
EVH
$475M
$132K ﹤0.01%
+10,471
New +$166K
CHY
1069
Calamos Convertible and High Income Fund
CHY
$1.03B
$130K ﹤0.01%
+13,200
New +$142K
ZAGG
1070
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$130K ﹤0.01%
+14,225
New +$156K
BOCH
1071
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$128K ﹤0.01%
12,095
+43
+0.4% +$476
FLG
1072
Flagstar Bank National Association
FLG
$5.77B
$127K ﹤0.01%
3,717
-51
-1% -$1.76K
PCK
1073
DELISTED
Pimco California Municipal Income Fund II
PCK
$124K ﹤0.01%
+13,800
New +$117K
LXRX icon
1074
Lexicon Pharmaceuticals
LXRX
$1.02B
$120K ﹤0.01%
21,535
+8,455
+65% +$51.4K
MRAM icon
1075
Everspin Technologies
MRAM
$354M
$115K ﹤0.01%
+15,000
New +$109K

Similar funds

D.A. Davidson & Co's Q1 2019 Portfolio in Review

As of Q1 2019, D.A. Davidson & Co held 1,206 positions worth $5.82B, up 13% from $5.13B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

D.A. Davidson & Co's Q1 2019 filing shows 115 new, 561 increased, 374 reduced and 73 closed positions. Its largest new stake was Invesco S&P 500 Pure Value ETF: 34,731 shares worth $1.98M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $5.89M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 9% a quarter earlier, followed by Industrials and Financials.

  • D.A. Davidson & Co's largest Q1 2019 buy was Invesco S&P 500 Pure Value ETF: 34,731 shares worth $1.98M.
  • D.A. Davidson & Co added most to Vanguard Value ETF in Q1 2019, an estimated $10.2M increase.
  • D.A. Davidson & Co's biggest Q1 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.07M.
  • D.A. Davidson & Co fully exited JPMorgan Ultra-Short Income ETF in Q1 2019, selling an estimated $5.89M.
  • D.A. Davidson & Co's ten largest holdings make up 30% of its $5.82B portfolio in Q1 2019.
  • D.A. Davidson & Co opened 115 new positions and closed 73 in Q1 2019.
  • D.A. Davidson & Co's portfolio value rose 13% quarter-over-quarter to $5.82B.

Based on D.A. Davidson & Co's 13F filing for Q1 2019, filed 13 May 2019.